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Available online 27 January 2012AbstractAims: The EURECCA (European Registration of Cancer Care) consortium is currently formed by nine independently founded national
colorectal audit registrations, of which most already run for many years. The cumulative experience of EURECCA’s participants could
be used to identify a ‘core dataset’ that covers all important aspects needed for high quality auditing and at the same time lacking needless
data items that only consumes administrative effort. The aim of this study is to compare the data items used by the nine registries partici-
pating in EURECCA to identify a core dataset and explore options for future research.
Methods: All colorectal outcome registrations participating in the EURECCA project were asked to supply a list with all the data items they
score. Items were scored ‘present’ if they appeared literally in a registration or in case they could be calculated using other items in the same
registration. The definition of a ‘shared data item’ was that at least eight of the nine participating registries scored the item.* Corresponding author. Tel.: þ31 71 526 2309; fax: þ31 71 526 6750.
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468 W. van Gijn et al. / EJSO 38 (2012) 467e471Results: The number of registered data items varied between 254 (Belgium) and 83 (Norway). Among the 45 variables were patient data,
data about preoperative staging, surgical treatment, pre- or postoperative radio- and/or chemotherapy, and follow-up. Items about tumour
recurrence or quality of life were scored too little to become shared data items.
Conclusions: A total of 45 items were collected by 8 or more of the participating registries and subsequently met the criteria for a shared
data item.
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In 2006, colorectal cancer caused over 200,000 deaths in
Europe, making it the second most common cause of can-
cer related death, while its incidence is still increasing.1 In
developing countries, the rise in incidence is even higher,
while they have the worst outcome.2e4 Although surgery
is the cornerstone for curative treatment, there is great var-
iability in outcomes among surgeons and institutions.
Quality of health care has a high priority on the political
agenda of most European countries. Universal health care
improvement initiatives, such as the development of a pre-
operative surgical checklist by the World Health Organiza-
tion, reflect the contemporary global commitment to
prioritizing high quality care within surgery.5
Surgical quality assurance program, also called surgical
audit, is a quality instrument that collects detailed clinical
data from different health care providers, which can be ad-
justed for baseline risk and subsequently fed back to individ-
ual hospitals or surgeons. Major improvements have been
achieved with national audits.6e8 However, although all the
national audits achieved excellent results, differences in
treatment and outcome remain between European countries
and cannot be easily explained.9 To reduce those differences
by identifying and spreading best practice, the European
CanCerOrganisation (ECCO) initiated an international,mul-
tidisciplinary, outcome-based quality improvement pro-
gram: European Registration of Cancer Care (EURECCA).
The goal is to create a multidisciplinary European registra-
tion structure for patient, tumour, and treatment characteris-
tics linked to outcome registration. Many important topics
that are unanswered by randomised controlled trials could
be researched using the data of EURECCA project. The
EURECCA project makes use of existing national audit reg-
istrations and started with colorectal cancer, but in the future
other solid tumour types, such as breast cancer, gastric can-
cer, and oesophageal cancer, will follow.
Unfortunately, clinical auditing comes with a price. De-
spite rapid development in medical information technology,
clinical auditing still is a considerable administrative bur-
den from medical professionals. A beautifully designed
but very detailed registry that turns out to be too time con-
suming to complete is worthless. Therefore, it is important
only to register those items that really matter. When a new
audit is set up, dedicated professionals might be tempted todevelop a very complete, although unnecessary large data-
set. Instead of reinventing the wheel, a ‘core dataset’ dis-
tilled from existing audits could save much energy.
TheEURECCAconsortiumiscurrentlyformedbynineinde-
pendentlyfoundednationalcolorectalauditregistrations,most
ofwhomalreadyrunformanyyears.Thecumulativeexperience
ofEURECCA’sparticipantscouldbeusedtoidentifya‘coredata-
set’thatcoversallimportantaspectsneededforhighqualityaudit-
ing and at the same time lacking needless data items that only
consumesadministrativeeffort.
Even more important than being used as a template for
other audits, an EURECCA core set will give the consor-
tium insight in what research can be performed in the
near future.
The objective of this study is to compare the data items
used by the nine registries participating in EURECCA to
identify a core dataset and explore options for future re-
search within the EURECCA project.
Methods
All colorectal outcome registrations participating in the
EURECCA project were asked to supply a list with all the
data items they score. These data items were entered in a da-
tabase and assigned to a main category and a subcategory.
Itemswere scored ‘present’ if they appeared literally in a reg-
istration or in case they could be calculated using other items
in the same registration. Secondly, the type of data (categor-
ical, number, yes/no, free text) was scored. Software used for
data input and analyseswas SPSS 17 (PASW,Chicago). After
all the items were entered in the database, a report was sent
back to the national data managers to check for errors or in-
completeness’. The corrected lists were returned and pro-
cessed in the database. In the corrected and completed
database, shared data items between the registries were iden-
tified aswell as resemblances in data type and categories. The
definition of a ‘shared data-item’ was that only one registry
was allowed not to score the item, so at least eight of the
nine participating registries scored the item.
Results
All nine participating EURECCA registries (Table 1)
supplied lists with all recorded data items, which were en-
tered into a database and checked for accuracy as described
Table 1
The EURECCA consortium.
Name Country Number of
included patients
(mid 2011)
Dutch Surgical Colorectal
Audit (DSCA)
The Netherlands 25,000
International Quality Assurance
in Colorectal Carcinoma
Germany
Poland
Italy (Naples)
Lithuania
76,000
Norwegian Colorectal Cancer
Project
Norway 26,500
Swedish Colorectal Cancer
Registry
Sweden 41,000
Danish Colorectal Cancer
Database
Denmark 36,500
National Bowel Cancer Audit
Program (NBOCAP)
United Kingdom 200,000
Project on cancer of the Rectum
(PROCARE)
Belgium 4500
Spanish TME project Spain 7500
Study group for Therapies Of
Rectal Malignancies (STORM)
Italy 1500
EURECCA 418,500
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varied between 254 (Belgium) and 83 (Norway) (Fig. 1). A
total of 45 items were collected by 8 or more of the partici-
pating registries and subsequently met the criteria for
a shared data-item (Table 2). Among the 45 variables
were patient data such as date of birth, gender, cancer
type and ASA score. Furthermore, variables to score the
use of endoscopy, rectal ultrasound, CT or MRI scan for
preoperative staging met the shared data item criteria to-
gether with cT-stage and cM-stage. Items about the surgical
treatment that met the criteria for a shared data item in-
cluded date of surgery, main procedure, open or laparo-
scopic, the creation of an anastomosis and/or stoma and
the important postoperative complication; anastomotic
leakage. Eight or more out of the nine participatingFigure 1. Number of recorded data items for all EURECCA paregistries scored pTNM stage, radicality and distance of
the tumour to the surgical resection plane. Registrations
of administered pre- or postoperative radio- and or chemo-
therapy were also shared data items. Regarding follow-up,
death status and date of death were shared data items. Items
about tumour recurrence or quality of life were scored too
little to become shared data items.
Fig. 1 shows the number of recorded data items scored
by all nine EURECCA participants on the Y axis and the
number of years since first registration on the X axis. There
was no relation between time since first registration and the
number of scored data items.Discussion
After comparing the datasets of EURECCA’s nine par-
ticipating registries, a list of 45 data items could be identi-
fied as a shared, core dataset. A strong variation between
the number of data items collected by different registries
was found, ranging between 83 by Norway and 254 by Bel-
gium. Despite the fact that the oldest registry (Norway)
used the fewest data items, there was no relation between
time since first registration and slimness of the dataset.
Although many important items can be mentioned that
are not listed in the core dataset, the most vital variables
about patient, disease, preoperative staging, operation, pa-
thology and survival are all part of the core dataset. Further-
more, data about pre- and postoperative adjuvant treatment
are also part of the core dataset.
Worldwide and also within Europe, there are many dif-
ferences in the use of (neo)adjuvant treatment for cancer.
For instance, for rectal cancer with an unthreatened circum-
ferential resection margin, many patients will receive short
term (5  5 Gy) preoperative radiotherapy while others will
get long course radiochemotherapy and sometimes this is
administered postoperatively. Using the shared data items
in combination with the impressive and unprecedented
amount of patients supplied by EURECCA, an inventory
about differences in (neo)adjuvant treatment can be maderticipants, including time since first registration in years.
Table 2
Data items shared by 8/9 registrations.
Category Data item
Patient: administrative data Patient number
Cancer type (rectal, colon)
Neo-adjuvant therapy (type: none,
RT, CT, RCT)
Adjuvant therapy (type: none,
RT, CT, RCT)
Gender
Patient name
Hospital
Date of birth
Radiotherapy: type (preop/postop)
and duration (long/short course)
Patient: preoperative medical
condition
ASA score
Preop staging: Colonoscopy,
location tumour, biopsy,
complications
Endoscopy: lower limit from anal
verge (cm)
Endoscopy: y/n
Preop staging: Imaging CT scan
Ultrasound rectal
MRI scan
MRI e cT-stage
Preop staging: Final preop
staging, MDT, other
cM Clinical metastases: y/n
Final preop diagnosis: cT-stage
Final preop diagnosis: cM-stage
Neo-adjuvant treatment: Type,
technique, dose, etc
Preoperative chemotherapy
Preoperative radiotherapy
Operation: Type, technique,
anastomosis, stoma, etc
Operation: y/n
Operation: date
Main procedure (ICD10 or
translatable into)
Surgery: stoma (none,
decompressive, permanent,
loop, endtype)
Surgical access for resection:
(laparotomy/laparoscopy/converted
laparoscopy/local excision)
Surgery: Anastomosis
Resection of adjacent organ
Operation: Complications Postoperative anastomotic leakage
Postop staging: Pathology,
final diagnosis
Primary diagnosis (ICD10)
Distant metastasis
Histology (SNOMED)
pTNM: T
pTNM: N
pTNM: M
Tumour stage (TNM 6th edition)
Lymph nodes with metastases
Lymph nodes in total
Distance to surgical resection plane
(CRM)
Radicality operation (R0, R1, R2)
Location distant metastases (liver,
lung, peritoneum, omentum,
ovary, lymp node)
Adjuvant treatment: RT, CT,
RCT, type, technique, dose, etc
Postoperative chemotherapy
Postoperative radiotherapy
Follow-up: Date, Death status,
Oncological status
Death/alive
Date of death
Total 45
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cal radicality and long term survival. The EURECCA core
dataset offers enough patient data to perform statistical cor-
rections for patient and tumour factors, necessary for a fair
comparison between different treatments.
While the share of elderly in the incidence of colorectal
cancer is increasing every year, elderly are remarkably
enough excluded from most clinical trials concerning colo-
rectal cancer. Again, the extensive data of EURECCA’s
core dataset should be able to answer vital questions about
the optimal treatment for elderly. Differences in treatment
can be identified as well as differences in first presentation
of disease, whether this is tumour stage, age, gender or in-
cidence of a disease.
In conclusion, a valuable core data set is identified. This
study shows a lean and easy to register core dataset that can
help starting clinical audits setting up their database and help
minimize administrative burden for existing audits. Most im-
portantly, vital research questions will be answered in the
near future using the power of EURECCA’s merged data.Acknowledgements
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